XML 94 R83.htm IDEA: XBRL DOCUMENT v3.25.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Thousands
 3 Months Ended
Dec. 06, 2022
USD ($)
payment
Mar. 31, 2025
USD ($)
liability
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jan. 31, 2021
USD ($)
Dec. 31, 2019
USD ($)
Loss Contingencies [Line Items]            
Payment for contingent consideration   $ 2,600   $ 0    
Arkis            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)           $ 25,500
Contingent consideration           13,100
Arkis | Development Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)           10,000
Payment for contingent consideration   $ 5,000        
Arkis | Commercial Sales Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)           $ 15,500
Derma Sciences            
Loss Contingencies [Line Items]            
Number of liabilities | liability   1        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)   $ 3,000        
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments            
Loss Contingencies [Line Items]            
Payment for contingent consideration   $ 33,300        
ACell, Inc.            
Loss Contingencies [Line Items]            
Number of liabilities | liability   1        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)         $ 23,900  
ACell, Inc. | Revenue-Based Performance Milestones In 2023            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)         $ 100,000  
Surgical Innovation Associates, Inc.            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) $ 90,000          
Business acquisition, number of payments | payment 2          
Surgical Innovation Associates, Inc. | Revenue Based Performance Milestones            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) $ 32,600          
Payment for contingent consideration     $ 12,400      
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) 50,000          
Surgical Innovation Associates, Inc. | FDA Approval Of Premarket Approval            
Loss Contingencies [Line Items]            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) 25,000          
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to) $ 40,000